Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy

Acute myeloid leukemia (AML) is an aggressive malignancy, and many elderly/unfit patients cannot receive intensive and potentially curative therapy. These patients receive low-toxicity disease-stabilizing treatment. The combination of all-trans retinoic acid (ATRA) and the histone deacetylase inhibi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ida Sofie Grønningsæter, Hanne Kristin Fredly, Bjørn Tore Gjertsen, Kimberley Joanne Hatfield, Øystein Bruserud
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2019-10-01
Colección:	Cells
Materias:	acute myeloid leukemia all-trans retinoic acid lipids metabolomics valproic acid
Acceso en línea:	https://www.mdpi.com/2073-4409/8/10/1229
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!